MW
Publicaties op Oncologisch.com
Chronological survival improvement over time with oxaliplatin-based chemotherapy plus targeted agents in metastatic c...
Risk Factors for Locoregional Relapse After Segmentectomy: Supplementary Analysis of the JCOG0802/WJOG4607L Trial.
Segmentectomie versus lobectomie bij kleine perifere NSCLC: JCOG0802 fase III
Irinotecan-cisplatine versus etoposide-cisplatine bij limited-stage SCLC: fase III
Vergelijking van behandelinvasiviteit: primaire debulking versus intervaldebulking na neoadjuvante chemotherapie bij ovariumcarcinoom